Skip to main content
Caplight Logo









Craniometrix

Craniometrix

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.craniometrix.com/

Last Round

Series A

Mar 30, 2026

Est. Valuation

$21M

Total Funding Raised

$51.5M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Craniometrix is a healthcare technology company that provides an AI-powered care navigation platform for Alzheimer's and dementia patients and their caregivers.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Clinical Trials, Vertical SaaS

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

dementia carecognitive assessmentneuro-diagnostic softwarecare navigationMedicare GUIDE programcaregiver supporthealthtechvertical SaaSclinical workflow automationneurological data analysisAI care coordinationremote patient monitoringRPMdigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Craniometrix Comparables

Compare Craniometrix with similar companies based on industry and business-model similarity.

Craniometrix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Altoida, Inc.
87%
Linus Health
81%
BrainCheck
79%

Craniometrix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 30, 2026
Series AFeb 27, 2026
Series AJan 1, 2026
SeedAug 10, 2022
AcceleratorMar 1, 2022

Craniometrix Investors

Notable investors and investment history

Craniometrix investors
InvestorRounds
J VenturesSeries A, Seed
Defy Partners ManagementSeries A, Seed
AGI HouseSeries A
Y CombinatorSeries A, Seed, Accelerator
Cathexis VenturesSeries A, Seed
Rebel FundSeries A, Seed
Quiet CapitalSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 44% MoM.

  • Jul 23, 2026

    Reached $8M in Annual Recurring Revenue in its first year.

Craniometrix Filings

Explore SEC and related filing metadata, where available.

Craniometrix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Craniometrix's valuation, stock price, and market status.

Is Craniometrix a public or private company?

Craniometrix is a private company.

What is the current stock price of Craniometrix?

Craniometrix is a private company with no public stock price. No recent secondary market data is available.

How much is Craniometrix worth (valuation)?

Valuation information for Craniometrix is not publicly available.

Can I buy Craniometrix stock?

Craniometrix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Craniometrix's last funding round?

Craniometrix's most recent funding round was Series A on March 30, 2026.

Who are the main investors in Craniometrix?

Key investors in Craniometrix include Y Combinator.

Will Craniometrix IPO soon?

No public IPO plans have been announced for Craniometrix.

How can I track Craniometrix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Craniometrix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range34
Year Founded2022
Last FundingMar 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?